AL amyloidosis:

An epidemiological and clinical challenge 

Autor: Jiménez Zepeda Víctor Hugo

Fragmento

Dear Editor: I have read with great interest the recent manuscript published in your Journal entitled: Systemic Immunoglobulin light chain amyloidosis in Mexico: a single institution, 30 year experience. I would like to congratulate the authors for trying to give us a better clinical and biological understanding on this rare entity not fully reported in the Mexican literature before.

Palabras clave:

2013-10-11   |   607 visitas   |   Evalua este artículo 0 valoraciones

Vol. 65 Núm.4. Julio-Agosto 2013 Pags. 357-358 Rev Invest Clin 2013; 65(4)